Navigation Links
Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
Date:6/25/2010

CAMBRIDGE, Mass., June 25 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression. Anti-GITR agents have been identified by the National Cancer Institute as having high potential for treating cancer.  The preclinical data were presented and recognized as a distinguished abstract at the annual meeting of the Federation of Clinical Immunology Societies in Boston, Massachusetts.

The data included in the presentation demonstrated that a murine analog of TRX518, which is an anti-GITR antibody, resulted in pronounced and durable immune responses to several antigens in mice. These data also showed that the TRX518 analog, when combined with gemcitabine, a standard chemotherapeutic, significantly reduced tumor burden (p<0.001) and prolonged survival (p<0.001) in the mouse model when compared with gemcitabine alone. In particular, of the mice treated with the combination therapy, 65% had a complete remission. Similar findings were observed when the TRX518 analog was combined with cyclophosphamide. The humanized monoclonal antibody, TRX518, blocked the interaction of GITR with its ligand, enhanced the cytotoxicity of human natural killer cells, downmodulated GITR on peripheral blood lympocytes, did not induce appreciable cytokine release, and was well tolerated and safe at high doses in non-human primates.

"We are highly
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
2. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
3. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
4. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
5. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
6. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
7. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
8. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
9. Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients
10. Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
11. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Acsis Inc., the market leader for supply chain visibility, ... John DiPalo , Acsis, Chief Strategy Officer, has been ... 2015 Provider Pro to Know. The award recognizes ... prepare their companies, and customers, supply chains for the ... of Provider Pros to Know is featured in ...
(Date:2/27/2015)... 27, 2015 Securities lawyers at Dunnam ... Pharmaceuticals, Ltd. (NASDAQ: SLXP ) in connection ... SLXP investors are encouraged to contact attorney Hamilton Lindley ... investigation focuses upon the shareholder value of the transaction. ... receive only $158.00 per share in cash. At least ...
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive campaign ... cut the rate of infection with a dangerous drug-resistant ... Clostridium difficile, or C.diff, is a bacterium ... inflammation of the colon. A recent article in the ... difficile Infection in the United States ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3
... 28 Draeger Medical, Inc., an ... sponsoring a series of educational webinar events designed for ... Clinical Engineers, Biomedical Engineers and other key stakeholders in ... and deployment of wireless patient care solutions within their ...
... Who would,ve guessed that among all the tragic ... that a brain tumor patient would be treated ... is helping out by donating the treatment, care, ... with a pituitary gland tumor. ( www.cyberknifemiami.com ) ...
Cached Medicine Technology:Draeger Announces Sponsorship of Educational Initiatives Focusing on Wireless Advances for Healthcare 2CyberKnife Center of Miami Lends a Hand in Treatment of Haitian Nurse 2
(Date:2/28/2015)... Cruz, california (PRWEB) February 28, 2015 In ... ever growing number of practicing physicians as a way for ... training or education regarding Cannabis as medicine. Since the FDA ... been very few resources available to licensed physicians that ... to a patient. Dr. Deborah Malka in Santa Cruz, ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The Heart ... now a distributor of the machine. The Heart Fit ... their license, like a franchise model. The goal is ... and reverse heart disease. To buy External Counterpulsation ... Clinic can help individuals through this process and achieve ...
(Date:2/28/2015)... Indosoft Inc , developers of Q-Suite, ... pleased to announce the development of Q-Suite 5.9. Building ... of Q-Suite, this new version will include enhancements to ... features to the leading edge call center software. General ... add features to enhance security and protection. Administrators will ...
(Date:2/28/2015)... Louis, MO (PRWEB) February 28, 2015 ... leading provider of outsourced sales, marketing and supply ... their client, BIOTA Botanicals, is bringing its award ... Celebrated worldwide, BIOTA Botanicals’ products are specifically created ... herbal care experts, BIOTA is committed to marrying ...
(Date:2/28/2015)... How would you describe your ... are all kinds of different leaders, each with ... the advantages and applications of different leadership styles, ... new product this spring called The Leadership Report ... between personality type, leadership, and success. The Leadership ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
... Three-fourths opt for breast-conserving treatments instead, study finds, , TUESDAY, ... women diagnosed with breast cancer are not turning to mastectomy ... more conservative approaches, such as lumpectomy, a new survey has ... of the Journal of the American Medical Association , ...
... ... Network. , ... October 13, 2009 -- Agilex Technologies, Inc. , an enterprise application, solution and advisory ... today announced the appointment of Melissa Chapman to the newly-created position of Vice President for ...
... Red Mango, the fastest-growing retailer of authentic nonfat ... flavor, Pumpkin Spice , to celebrate the favorite ... to discover Pumpkin Spice frozen yogurt, available ... time, beginning today, October 13, through December 31, 2009. ...
... , The Institute for Palliative Medicine in San ... first statewide consultative service for palliative care ... professionals in California communities lacking palliative medicine resources ... educational support through a new hotline provided by The ...
... Electronics (NYSE: PHG, AEX: PHI) today introduced the next ... at Medtrade 2009, the leading conference and expo ... the new product line brings significant advancements in therapy ... to healthcare providers to help meet today,s healthcare challenges. ...
... "bubble boy" and many will recall David Vetter, the kid with ... 25 years ago after spending almost the entire 12 years of ... with severe combined immune deficiency, or SCID, a condition that robbed ... however, researchers have refined treatment options for children with SCID, and ...
Cached Medicine News:Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 2Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 3Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 2Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 3Health News:Discover Red Mango's New Seasonal Flavor: Pumpkin Spice 2Health News:New Palliative Medicine Hotline Reaches California 2Health News:New Palliative Medicine Hotline Reaches California 3Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 2Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 3Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 4Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 5Health News:SCID kids leading healthy, normal lives 25 years after 'Bubble Boy' 2Health News:SCID kids leading healthy, normal lives 25 years after 'Bubble Boy' 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: